article thumbnail

Does DIY still have a place in diabetes care? 

STAT

When Dana Lewis built her first artificial pancreas in 2014, she — and millions of other people with type 1 diabetes — didn’t have another option. Since then, the community of DIYers with type 1 diabetes has grown to the thousands.

Diabetes 244
article thumbnail

STAT+: For Parkinson’s disease, advances spurred by Apple Watch offer a glimmer of hope

STAT

Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as a high tech fashion accessory, but also as a way for people to track their own health and fitness. It has evolved as a popular cardio tool for such uses as heart rate monitoring, recording your ECG, and measuring the oxygen saturation of your blood.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re reading about a Merck deal, weight loss drugs, and lots more

STAT

The insurer analyzed pharmacy and medical claims of nearly 170,000 people between July 2014 and December 2023 and found 58% did not complete a 12-week course of the medicines. Yet recent studies found that Black people with diabetes are less likely to be prescribed GLP-1 drugs. Continue to STAT+ to read the full story…

Diabetes 253
article thumbnail

Soft launch of first indigenous antibiotic to combat AMR, Nafithromycin, announced by Dr Jitendra Singh

Express Pharma

It is only after 2014, when Prime Minister Narendra Modi took over that our researchers received the right kind of support to explore their potential, said Dr Jitendra Singh. Union Minister Dr Jitendra Singh formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections.

Diabetes 105
article thumbnail

FDA accepts Lilly-Boehringer Ingelheim’ sNDA for Jardiance

Pharmaceutical Technology

Jardiance was initially approved in 2014 as a once-a-day tablet for use with diet and exercise to reduce blood sugar in type 2 diabetes adult patients. It has also been approved for reducing cardiovascular death risk in type 2 diabetes and known cardiovascular disease adult patients.

Diabetes 105
article thumbnail

FDA ends 7-year obesity drug drought, clearing Novo Nordisk’s Wegovy

pharmaphorum

Already approved at a lower dose as Ozempic for treating diabetes, the new 2.4 mg once-weekly formulation – which will be sold as Wegovy – is the first new medicine to be approved in the US for obesity since 2014. Photo by i yunmai on Unsplash.

article thumbnail

Chronic kidney disease: treating a silent killer

pharmaphorum

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease. It was initially developed for type 2 diabetes and was approved for this indication in 2014. The DAPA-HF and DAPA-CKD trials were launched, including patients with and without type 2 diabetes.

Diabetes 119